Análisis Argos
HTFL
HTFLSin veredicto1 señal de riesgo
Heartflow, Inc. Common Stock · Healthcare
US$ 27.97
precio al 2026-07-04
Valor justo Argos*
Sin estimar
vs. su valor justo
Sin estimar
Score Argos
24/100
Sin veredicto
LA RESPUESTA
No tenemos un veredicto de valuación confiable acá: su flujo de caja no permite una estimación sólida. Mirá su calidad y su salud para formarte una idea — preferimos eso a inventarte un número.
Recompensas
✓Tiene más caja que deuda: balance fuerte.
Riesgos
!Venta significativa de insiders en el último trimestre.
!Balance frágil: la deuda pesa sobre el negocio.
!Altman Z'' en zona roja (-2.45)
VALOR1/6FUTURO5/6PASADO2/6SALUD1/6DIVIDENDO1/6
El Iris de calidad
VALOR1/6FUTURO5/6PASADO2/6SALUD1/6DIVIDENDO1/6
ValorCotiza por encima de su valor justo
FuturoIngresos creciendo con fuerza
PasadoHistorial aceptable
SaludBalance frágil
DividendoEl dividendo aún duerme
Score Argos24de 100Sin veredicto
Ingresos▲38%
US$ 0.2 B
Margen operativo▼25%
-36.4%
Flujo de caja libre▼14%
US$ -0.1 B
Deuda neta
US$ -0 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 2.4B
P/E—
EV/EBITDA—
FCF yield-2.4%
ROIC-23%
Margen operativo-36.4%
Crecim. ingresos+39.9%/año
Piotroski F5/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

fool.com · 24 jun
HeartFlow vs. NovoCure: Which Emerging Healthcare Stock Is a Better Buy in 2026?
AI-powered diagnostics meet global oncology innovation as two medical disruptors post strong revenue growth, yet face distinct risk and valuation profiles.
seekingalpha.com · 8 jun
Baron Discovery Fund Q1 2026: Who Moved The Needle
In the first quarter of 2026, Baron Discovery Fund declined 10.65% (Institutional Shares), trailing the Russell 2000 Growth Index by 7.84% due to significant underperformance in the software sector. Advanced Energy Industries, Inc.'s stock rose during the quarter as the market began to appreciate the strength that the company would see in both its data center and semiconductor end markets. Baron Discovery Fund sold its investment in Intapp, Inc. in the quarter as the team believes that its other software holdings have better overall competitive advantages.
fool.com · 31 may
Is HeartFlow Stock a Buy After an Institutional Investor Initiated a Position Worth $2.7 Million?
HeartFlow delivers AI-powered, non-invasive cardiac diagnostics for hospitals and cardiology clinics using proprietary imaging technology.
marketbeat.com · 14 may
Heartflow Q1 Earnings Call Highlights
Heartflow NASDAQ: HTFL reported a sharply higher first-quarter revenue total and raised its full-year 2026 outlook, citing strength in its core FFRCT business, faster-than-expected adoption of its Plaque Analysis product and continued expansion of the coronary CT angiography, or CCTA, market.
seekingalpha.com · 14 may
HeartFlow, Inc. (HTFL) Q1 2026 Earnings Call Transcript
HeartFlow, Inc. (HTFL) Q1 2026 Earnings Call Transcript
globenewswire.com · 14 may
Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the first quarter ended March 31, 2026.
fool.com · 12 may
Wall Street Waits for the SpaceX IPO, These 2 Under-the-Radar IPOs Could Already Be Making You Money
Heartflow and Neptune Insurance deserve a closer look.
fool.com · 8 may
Stanford Trustees Exited HeartFlow Stock for $8.5 Million. Here's What That Means for Investors.
HeartFlow provides AI-driven tools for non-invasive heart diagnostics, serving hospitals and clinics with advanced cardiovascular insights.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.